Esther Mena

Esther Mena

UNVERIFIED PROFILE

Are you Esther Mena?   Register this Author

Register author
Esther Mena

Esther Mena

Publications by authors named "Esther Mena"

Are you Esther Mena?   Register this Author

64Publications

1683Reads

23Profile Views

Human Radiation Dosimetry of Orally or Intravenously Administered F-Fluorodeoxyglucose.

J Nucl Med 2019 Oct 18. Epub 2019 Oct 18.

Department of Radiology, Johns Hopkins University School of Medicine, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.119.233288DOI Listing
October 2019

New Targets for PET Molecular Imaging of Prostate Cancer.

Semin Nucl Med 2019 07 9;49(4):326-336. Epub 2019 Mar 9.

Molecular Imaging Program, National Cancer Institute, NIH. Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2019.02.001DOI Listing
July 2019

PET imaging in renal cancer.

Curr Opin Oncol 2019 May;31(3):216-221

Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465137PMC
May 2019

Novel Imaging in Detection of Metastatic Prostate Cancer.

Curr Oncol Rep 2019 Mar 5;21(4):31. Epub 2019 Mar 5.

Molecular Imaging Program, National Cancer Institute, NIH, Building 10 - Room B3B85, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0780-8DOI Listing
March 2019

Combined model-based and patient-specific dosimetry for F-DCFPyL, a PSMA-targeted PET agent.

Eur J Nucl Med Mol Imaging 2018 06 19;45(6):989-998. Epub 2018 Feb 19.

The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00259-018-3939-x
Publisher Site
http://dx.doi.org/10.1007/s00259-018-3939-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918228PMC
June 2018

Imaging Locally Advanced, Recurrent, and Metastatic Prostate Cancer: A Review.

JAMA Oncol 2017 Oct;3(10):1415-1422

Molecular Imaging Program, National Cancer Institute, National Institute of Health (NIH), Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.5840DOI Listing
October 2017

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.

Clin Nucl Med 2017 Oct;42(10):735-740

From the *Molecular Imaging Program, National Cancer Institute, Bethesda; †Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, Frederick, MD; ‡Institute of Diagnostic Radiology, Department of Medical Area, University of Udine, Udine, Italy; §Office of the Clinical Director/Center for Cancer Research/National Cancer Institute, Bethesda; ∥Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick; ¶Office of the Pharmaceutical Quality, FDA/CDER, Silver Spring; **Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore; ††Laboratory of Pathology, National Cancer Institute, Bethesda; ‡‡Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville; §§Center for Interventional Oncology, National Cancer Institute and Clinical Center, and Radiology Imaging Sciences, National Institutes of Health, Bethesda; and ∥∥Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703072PMC
October 2017

Precision Medicine and PET/Computed Tomography in Melanoma.

PET Clin 2017 Oct 14;12(4):449-458. Epub 2017 Jul 14.

Department of Radiology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Clinical Sciences, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA; Department of Biomedical Engineering, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA; Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15568598173004
Publisher Site
http://dx.doi.org/10.1016/j.cpet.2017.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701665PMC
October 2017

Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up F-FDG PET/CT Scans in Oncology Patients.

J Nucl Med 2017 05 3;58(5):737-743. Epub 2016 Nov 3.

Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.183111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414499PMC
May 2017

Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.

Clin Nucl Med 2017 May;42(5):e227-e234

From the *Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD; †Department of Radiology, ‡Department Clinical Sciences, §Advanced Imaging Research Center, and ∥Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380578PMC
May 2017

Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.

Nucl Med Commun 2017 Mar;38(3):250-258

aRussell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland bDepartment of Radiology cAdvanced Imaging Research Institute dDepartment of Clinical Sciences eDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360462PMC
March 2017

The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.

AJR Am J Roentgenol 2017 Feb 11;208(2):420-433. Epub 2016 Oct 11.

1 Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.16.16532DOI Listing
February 2017

18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.

Clin Nucl Med 2017 Jan;42(1):e16-e21

From the *Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD; and †Department of Radiology, and ‡Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360463PMC
January 2017

Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.

PET Clin 2017 Jan 5;12(1):105-118. Epub 2016 Oct 5.

Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Johns Hopkins University, 601 North Caroline Street, Baltimore, MD 21287, USA; Department of Radiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Department of Biomedical Engineering, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA; Advanced Imaging Research Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2016.08.002DOI Listing
January 2017

Molecular Imaging and Precision Medicine in Head and Neck Cancer.

PET Clin 2017 Jan 5;12(1):7-25. Epub 2016 Oct 5.

Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Johns Hopkins University, 601 North Caroline Street, Baltimore, MD 21287, USA; Department of Radiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8896, USA; Department of Clinical Sciences, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9096, USA; Department of Biomedical Engineering, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-8896, USA; Advanced Imaging Research Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-8896, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2016.08.009DOI Listing
January 2017

Practical no-gold-standard evaluation framework for quantitative imaging methods: application to lesion segmentation in positron emission tomography.

J Med Imaging (Bellingham) 2017 Jan 3;4(1):011011. Epub 2017 Mar 3.

University of Texas Southwestern Medical Center , Department of Radiology and Advanced Imaging Research Center, Dallas, Texas, United States.

View Article

Download full-text PDF

Source
http://medicalimaging.spiedigitallibrary.org/article.aspx?do
Publisher Site
http://dx.doi.org/10.1117/1.JMI.4.1.011011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335899PMC
January 2017

Advancement of MR and PET/MR in Prostate Cancer.

Semin Nucl Med 2016 Nov 3;46(6):536-543. Epub 2016 Sep 3.

Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2016.07.001DOI Listing
November 2016

Evaluation of Prostate Cancer with PET/MRI.

J Nucl Med 2016 Oct;57(Suppl 3):111S-116S

Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.169763DOI Listing
October 2016

18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.

Clin Nucl Med 2016 Sep;41(9):e403-9

From the *Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, MD; †Boston University School of Medicine, Boston, MA; ‡Department of Oncology, Sidney Kimmel Comprehensive Cancer Centre, §Armstrong Institute for Patient Safety & Quality, Johns Hopkins School of Medicine; and ∥Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001275DOI Listing
September 2016

FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.

Oncologist 2016 08 8;21(8):931-9. Epub 2016 Jul 8.

Russell H. Morgan Department of Radiology and Radiological Sciences Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978549PMC
August 2016

JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.

AJR Am J Roentgenol 2016 Aug;207(2):257-65

1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St, JHOC 3235, Baltimore, MD 21287.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.15.15806DOI Listing
August 2016

The Current and Evolving Role of PET in Personalized Management of Lung Cancer.

PET Clin 2016 Jul 2;11(3):243-59. Epub 2016 May 2.

Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins School of Medicine, 401 North Broadway, Baltimore, MD 21231, USA; Armstrong Institute for Patient Safety & Quality, Johns Hopkins School of Medicine, 750 East Pratt Street, Baltimore, MD 21202, USA; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, 624 North Broadway, Baltimore, MD 21205, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2016.02.010DOI Listing
July 2016

18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.

J Nucl Med 2016 06 2;57(6):855-60. Epub 2016 Feb 2.

Russell H. Morgan Department of Radiology and Radiological Sciences, Baltimore, Maryland Department of Oncology of Johns Hopkins School of Medicine, Baltimore, Maryland; and Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/content/early/2016/02/01/jnumed.1
Web Search
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.115.165480
Publisher Site
http://dx.doi.org/10.2967/jnumed.115.165480DOI Listing
June 2016

18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction.

Nucl Med Commun 2016 Mar;37(3):231-8

aRussell H Morgan Department of Radiology and Radiological Sciences bDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine cDepartment of Health Policy and Management and Center for Health Services and Outcome Research, Johns Hopkins Bloomberg School of Public Health dArmstrong Institute for Patient Safety and Quality, Johns Hopkins Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000436DOI Listing
March 2016

Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.

Mol Imaging Biol 2015 Aug;17(4):565-74

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Cancer Research Bldg. 2, Room 492, 1550 Orleans St, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11307-015-0850-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531836PMC
August 2015

(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.

PET Clin 2015 Jul;10(3):423-30

Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, JHOC 3230, 601 North Caroline Street, Baltimore, MD 21287, USA; Department of Oncology, Johns Hopkins School of Medicine, 401 North Broadway, Baltimore, MD 21231, USA; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 North Broadway, Baltimore, MD 21205, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15568598150002
Publisher Site
http://dx.doi.org/10.1016/j.cpet.2015.03.011DOI Listing
July 2015

Comprehensive radionuclide esophagogastrointestinal transit study: methodology, reference values, and initial clinical experience.

J Nucl Med 2015 May 12;56(5):721-7. Epub 2015 Mar 12.

Division of Nuclear Medicine, Russell H. Morgan Department of Radiology and Radiological Sciences; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.114.152074DOI Listing
May 2015

A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.

Clin Nucl Med 2014 Oct;39(10):874-81

From the *Molecular Imaging Program, and †Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD; ‡Brookhaven National Laboratories, Upton, NY; and §SAIC Contractor to NCI, Fort Detrick Frederick, MD; and ¶Lymphoma Therapeutics Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838032PMC
October 2014

Brain PET in the diagnosis of Alzheimer's disease.

Clin Nucl Med 2014 Oct;39(10):e413-22; quiz e423-6

*Post Doctorate Research Fellow in the Russell H. Morgan, Department of Radiology and Radiological Sciences at Johns Hopkins University in Baltimore, MD; †Nuclear Medicine Resident in the Russell H. Morgan, Department ofRadiology and Radiological Sciences at Johns Hopkins University in Baltimore, MD; ‡Associate Professor in the Russell H. Morgan, Department of Radiology and Radiological Sciences, Department of Oncology, Department of Otolaryngology-Head and Neck Surgery at Johns Hopkins School of Medicine, and the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332800PMC
October 2014

Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.

J Nucl Med 2014 Sep 19;55(9):1411-6. Epub 2014 Jun 19.

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.113.136796DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390037PMC
September 2014

Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.

Radiology 2014 Mar 8;270(3):849-56. Epub 2013 Nov 8.

From the Molecular Imaging Program (B.T., E.M., M.L.L., M.B., Y.L.M., S.A., P.L.C., K.A.K.), Biometric Research Branch, Division of Cancer Treatment and Diagnosis (J.S.), Urologic Oncology Branch (P.A.P.), and Laboratory of Pathology (M.J.M.), National Institutes of Health, National Cancer Institute, 10 Center Dr, MSC 1182 Bldg 10, Room B3B85 Bethesda, MD 20892-1088; and Medical Diagnostics Research and Development, GE Healthcare, Uppsala, Sweden (R.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.13130240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263644PMC
March 2014

Meeting the challenges of PET-based molecular imaging in cancer.

Expert Rev Mol Diagn 2013 Sep;13(7):671-80

Molecular Imaging Program, National Cancer Institute, Building 10, Room B3B69F, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2013.835568DOI Listing
September 2013

Reply: To PMID 22343504.

J Nucl Med 2013 Feb;54(2):326-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.112.114454DOI Listing
February 2013

The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.

J Nucl Med 2012 Aug 22;53(8):1175-84. Epub 2012 Jun 22.

Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.111.100883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474293PMC
August 2012

Review of functional/anatomical imaging in oncology.

Nucl Med Commun 2012 Apr;33(4):349-61

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1088, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0b013e32834ec8a5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295905PMC
April 2012

Current and future imaging modalities for multiple myeloma and its precursor states.

Leuk Lymphoma 2011 Sep 8;52(9):1630-40. Epub 2011 Jun 8.

Multiple Myeloma Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.573036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518908PMC
September 2011

Molecular imaging in myeloma precursor disease.

Semin Hematol 2011 Jan;48(1):22-31

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2010.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023940PMC
January 2011

Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.

Leuk Lymphoma 2010 Dec 20;51(12):2159-70. Epub 2010 Oct 20.

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2010.52
Publisher Site
http://dx.doi.org/10.3109/10428194.2010.525725DOI Listing
December 2010

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

Psychopharmacology (Berl) 2006 May 31;186(1):93-8. Epub 2006 Mar 31.

Centre d'Investigació de Medicaments, Institut de Recerca, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, and Departament de Farmacologia i Terapéutica, Universitat Autònoma de Barcelona, Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00213-006-0358-7
Publisher Site
http://dx.doi.org/10.1007/s00213-006-0358-7DOI Listing
May 2006

Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis.

Neuroimage 2006 Jan 19;29(2):662-6. Epub 2005 Aug 19.

Department of Psychiatry, Hospital de la Sta Creu I Sant PauC, Universidad Autónoma de Barcelona (UAB) [corrected] Sant Antoni Maria Claret, 16708025 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuroimage.2005.07.038DOI Listing
January 2006

Left ventricular end-diastolic volume is decreased at maximal exercise in athletes with marked repolarisation abnormalities: a continuous radionuclide monitoring study.

Eur J Nucl Med Mol Imaging 2005 Feb 16;32(2):203-10. Epub 2004 Sep 16.

Department of Nuclear Medicine, Hospital de la Santa Creu i Sant Pau, Sant Antoni M. Claret, 167, 08025, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-004-1652-4DOI Listing
February 2005

Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.

Prog Neuropsychopharmacol Biol Psychiatry 2005 Jan 23;29(1):91-6. Epub 2004 Nov 23.

Department of Psychiatry, Hospital de la Sta. Creu i St. Pau, Autonomous University of Barcelona (UAB) [corrected] Sant Antoni Maria Claret 167 08025 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S027858460400202
Publisher Site
http://dx.doi.org/10.1016/j.pnpbp.2004.10.010DOI Listing
January 2005

Challenging the neuronal MIBG uptake by pharmacological intervention: effect of a single dose of oral amitriptyline on regional cardiac MIBG uptake.

Eur J Nucl Med Mol Imaging 2004 Dec 19;31(12):1575-80. Epub 2004 Jun 19.

Department of Nuclear Medicine, Hospital Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-004-1520-2DOI Listing
December 2004

99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer.

Eur J Nucl Med Mol Imaging 2004 Oct 19;31(10):1399-404. Epub 2004 Jun 19.

Department of Nuclear Medicine, Sant Pau Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-004-1594-xDOI Listing
October 2004

Individual renal function based on 99mTc dimercaptosuccinic acid uptake corrected for renal size.

Nucl Med Commun 2004 Feb;25(2):167-70

Department of Nuclear Medicine, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/nuclearmedicinecomm/2004/02000/
Web Search
http://dx.doi.org/10.1097/00006231-200402000-00013DOI Listing
February 2004